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Objectives. This study sought to determine the success and 
complication rates of high speed rotational coronary atherectomy 
in calcified and noncalcified lesions. 
Background. Percutaneous transluminal coronary angioplasty 
and directional coronary atherectomy of calcified lesions are 
associated with reduced procedural success and increased com- 
plications. Rotational atherectomy using the Rotablator catheter 
abrades noncompliant plaque and may improve outcome in 
calcified lesions. 
Methods. Data from the completed Multicenter Rotablator 
Registry of 2,161 rotational atherectomy procedures in single 
lesions were analyzed to determine the relative efficacy of rota- 
tional atherectomy for 1,078 calcified and 1,083 noncalcified 
lesions. The power of the study was 0.86 to detect a significant 
difference in outcome, if the true success rates in the noncaicified 
and calcified lesions were 96% and 93%, respectively. 
Results. Patients with calcified lesions were older (mean [-+SD] 
age 66.2 -+ 10.3 vs. 60.5 -+ 11.0 years, p = 0.0001) than those with 
noncalcified lesions. Calcified lesions were more frequently new 
(75% vs. 64%, p = 0.0001), angulated (27% vs. 22%, p = 0.02), 
eccentric (75% vs. 64%, p = 0.0001) and long (32% vs. 27%, 
> 10 mm in length, p = 0.01). They were also more often complex 
(57% vs. 46%, p = 0.001) and located in the left anterior 
descending coronary artery (51% vs. 44%, p = 0.001). Adjunctive 
coronary angioplasty was used in 82.9% of calcified and 66.9% of 
noncalcified lesions. Procedural success, defined as <50% resid- 
ual stenosis without major complication, was achieved in 94.3% of 
calcified and 95.2% of noncalcified lesions (p = 0.32). Major 
complication rates were 4.1% in calcified and 3.1% in noncalcified 
lesions (p = 0.24). Non-Q wave myocardial infarction was docu- 
mented in 10.0% of calcified and 7.7% of noncalcified lesions (p = 
0.054). Mean postprocedural residual stenosis was 21.6 -+ 13.9% 
in calcified and 23.3 -+ 15% in noncalcified lesions (p = 0.39). 
Conclusions. In this review of data from a large multicenter 
registry, the success rate of rotational atherectomy was not 
reduced by calcification despite the more frequent complex nature 
of the calcified lesions. The Rotablator catheter is likely to be the 
device of choice for percutaneous intervention i calcified lesions, 
but definitive conclusions await the results of randomized trials. 
(JAm Coil Cardiol 1995;26:731-6) 
The success and complication rates of percutaneous coronary 
interventions are dependent on a number of patient- and lesion- 
specific characteristics. Although the overall success rate of 
percutaneous coronary balloon angioplasty and directional coro- 
nary atherectomy are >90% (1-3), success may be reduced and 
complications increased in the presence of lesion calcification. 
Bredlau et al. (4) identified lesion calcification as an independent 
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predictor of major complications after coronary angioplasty, an 
observation that has been confirmed by others (5,6). The recog- 
nition of reduced interventional success in complex lesions has led 
to the development ofalternative modalities of treatment, includ- 
ing high speed rotational atherectomy (7). Preliminary reports 
(8,9) have suggested an improved success rate in calcified lesions 
using the Rotablator system (Heart Technology Inc.). We re- 
viewed the data from the Multicenter Rotablator Registry (see 
Appendix) to determine the relative efficacy of high speed 
rotational atherectomy in calcified and noncalcified lesions. 
Methods 
Patient group. Data from a multicenter registry of 2,953 
rotational atherectomy procedures involving 3,717 lesions in 
2,700 patients were reviewed. The institutions contributing to 
this registry are listed in the Appendix, and inclusion and 
exclusion criteria are presented in Table 1. Patients provided 
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Table l. Inclusion and Exclusion Criteria for the Multicenter 
Rotablator Registry 
Inclusion criteria 
Target lesion >70% stenosis 
Patient must be candidate for coronary, artery bypass urgery 
Exclusion criteria 
Lesion >25 mm long 
Ejection fraction <30% 
Unprotected left main coronary artery disease 
Patients with occlusion through which a guide wire will not pass 
Angiographic evidence of thrombus pretreatment 
Severe diffuse three-vessel disease 
Extensive dissection within 1 mo of previous coronary angioplasty 
Vein graft lesions 
increase in postprocedural creatinine kinase (CK) levels in the 
absence of new electrocardiographic Q waves. 
Statistics. Continuous variables were expressed as mean 
values +_ SD and compared using a two-tailed Student  test. 
Outcomes were expressed as proportions and their variability 
as 95% confidence intervals. Categoric variables were com- 
pared by chi-square analysis. Logistic regression analysis was 
used to determine the independent effect of variables on 
outcome. The study had the power of 0.86 to detect a 
difference in outcomes at the alpha 0.05 level if the success 
rates in the noncalcified and calcified lesions were 96% and 
93%, respectively. All p values are reported; statistical signif- 
icance was accepted at p <- 0.05. 
informed written consent for the use of an investigational 
device, and the protocol was approved by the relevant institu- 
tional ethics committees. Only procedures involving the treat- 
ment of a solitary lesion were included in the analysis o that 
complications could be assigned to a specific lesion. Of 2,161 
procedures in single lesions, 1,078 involved calcified and 1,083 
noncalcified lesions. 
Procedure. The Rotablator catheter consists of an elliptic, 
diamond-coated burr connected by a flexible, Teflon-sheathed 
drive shaft to a gas-driven turbine. This burr rotates at up to 
190,000 rpm, abrading atherosclerotic lesions into particles 
generally <5/~m in diameter (7). The technique used with the 
Rotablator system has been previously described (10). After 
pretreatment of patients with aspirin and calcium channel 
blocking agents, a 9F to 10F sheath was introduced into the 
femoral artery and the appropriate 9F to 10F guiding catheter 
used, A temporary pacing wire was inserted when the vessel 
supplying the atrioventricular (AV) node was to be treated. 
After the administration of heparin, a specialized 0.009-in. 
guide wire (Heart Technology, Inc.) was positioned across the 
target lesion, ensuring that the radiopaque, 0.017-in. tip was 
free and distal to the segment to be treated. Then a burr (range 
1.25 to 2.50 ram) (Rotablator catheter, Heart Technology, 
Inc.) was used to treat the lesion. Burr size could be subse- 
quently increased or adjunctive coronary angioplasty per- 
formed at the operator's discretion. A typical example of a 
treated calcified lesion is presented in Figure 1. Angiograms 
were analyzed at the investigating center. Fifteen sites re- 
ported either caliper or quantitative angiographic measure- 
ments, and five reported visual assessments. 
Definitions. Calcification was defined as radiopacity at the 
site of the target lesion, visible on fluoroscopy. The extent of 
calcification was not graded. Lesions were assessed for the 
presence of eccentricity, length >10 mm, angulation --30 °, 
bifurcation, ostial location and total occlusion. Lesions were 
considered to be complex when they had two or more of these 
other angiographic features. Procedural success was defined as 
a <50% residual stenosis at the end of the procedure, without 
in-hospital death, Q wave myocardial infarction or urgent 
coronary artery bypass urgery. Non-Q wave myocardial infarc- 
tion was diagnosed when there was a two and a half-fold 
Results  
Patient characteristics. Patients with calcified lesions were 
older, were more often female, had more unstable angina, 
more frequently had multivessel coronary artery disease and 
had more previous coronary artery bypass urgery than those 
with noncalcified lesions. Both groups had a similar incidence 
of previous myocardial infarction and a similar mean ejection 
fraction (Table 2). 
Lesion characteristics. Mean preprocedural percent steno- 
sis was 82.9 = 11.7% for calcified and 83.4 _+ 11.4% for 
noncalcified lesions (p = 0.34). Calcified lesions were more 
frequently new lesions, more often >10 mm in length, more 
frequently eccentric and more often located in angulated 
segments han noncalcified lesions. There was no difference in
the incidence of ostial esions, complete occlusions or bifurca- 
tion lesions between groups (Table 3). Calcified lesions were 
more often complex (57% vs. 46%, p = 0.001) (Fig. 2) and 
more frequently located in the left anterior descending coro- 
nary artery (51% vs. 44%) and left main trunk (5% vs. 2%) and 
less frequently in the right coronary artery (28% vs. 30%) and 
circumflex artery (16% vs. 23%) (p = 0.001). 
Success and complication rates (Table 4). Procedural suc- 
cess rate was not different for calcified (94.3%) and noncalci- 
fled lesions (95.2%) (p = 0.32). Mean final burr/artery ratio 
was 0.70 _+ 0.93 for calcified and 0.77 + 0.15 for noncalcified 
lesions (p = 0.04). More calcified lesions were treated with 
post-Rotablator balloon angioplasty to achieve an optimal 
result than were noncalcified lesions (82.9% vs. 66.9%, p = 
0.0001). Balloon angioplasty was performed because the Rota- 
blator failed to reduce the target stenosis to <50% in 13.8% of 
calcified and 12.3% of noncalcified lesions (p = NS). The 
remaining 1,618 patients had adjunctive balloon angioplasty to 
optimize a successful (<50% residual stenosis) result. Proce- 
dural success was not reduced in the presence of calcification 
with increasing lesion complexity (Fig. 3). Mean postprocedure 
residual stenosis was 21.6 +_ 13.9% for calcified and 23.3 _+ 
15.0% for noncalcified lesions (p = 0.39). 
Angiographic complications. The procedure was associ- 
ated with angiographically apparent coronary dissection i  161 
(14.9%) of 1,078 calcified and 122 (11.3%) of 1,083 noncalci- 
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fled lesions (p = 0.01). Abrupt coronary closure occurred in 42 
(3.9%) calcified and 36 (3.3%) noncalcified lesions (p = 0.48). 
Coronary artery perforation complicated rotational atherec- 
tomy in 5 (0.46%) calcified and 11 (1.02%) noncalcified lesions 
Figure 1. Moderately calcified midcircumflex lesion in a diffusely 
diseased circumflex coronary artery (A) treated initially with a 1.25-mm 
Rotablator burr (B), then a 1.5-mm burr (C) and finally with a 2.5-ram 
balloon catheter (D). Angiograms courtesy of Simon Stertzer, MD. 
Table 2. Patient Baseline Characteristics 
Calcified Lesions Noncalcified Lesions p Value 
Mean age (yr) 66,2 _+ 10.3 60.5 +_ ll.0 0.0001 
Male gender 725/1,078 (67%) 789/1,083 (73%) 0.005 
Unstable angina 475/1,063 (45%) 420/1,067 (39%) 0.01 
Multivessel disease 660/1,066 ( 6%) 562/926 (48%) 0.03 
Prior CABG 212/1,060 (20%) 173/1,048 (17%) 0.04 
Prior MI 410/1,045 (39%) 453/1,053 (43%) 0.08 
Mean ejection fraction (%) 55.5 + 14.1 57.4 + 12.9 0.82 
Data presented are mean value _+ SD or number (%) of patients. CABG coronary, artery bypass graft surgery; 
MI = myocardial nfarction. 
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Table 3. Lesion Characteristics 
Calcified Lesions Noncalcified Lesions p Value 
Eccentric 799/1,066 (75%) 684/1,068 (64%) 0.000l 
New 768/1,027 ( 5%) 657/1,028 (64%) 0.0001 
Length >10 mm 338/1,045 (32%) 275/1,014 (27%) 0.0l 
Angulated 284/1,039 (27%) 227/1,021 (22%) 0.02 
Bifurcation 316/1.039 (30%) 279/1,023 (27%) 0.12 
Ostial t80/676 (27%} 131/551 (24%) 0.25 
Stenosis >90%* 268/1,078 (25%) 261/1,083 (24%) 0.68 
Total occlusion 48/1,078 (4.5%) 53/1,083 (4.9%) 0.63 
% stenosis 82.9 _+ l 1.7 83.4 _+ 11.4 0.34 
*Includes complete occlusions. Data presented arc mean wdue _+ SD or number (%) of lesions. 
(p = 0.13). No patients with perforation died, but four with 
perforated noncalcified lesions required urgent coronary artery 
bypass surgery. 
Clinical complications. The incidence of major complica- 
tions (death, Q wave myocardial infarction or urgent bypass 
surgery) was 4.1% in calcified and 3.1% in noncalcified lesions 
(p : 0.24). Fourteen deaths (1.3%) occurred in the calcified 
lesion group and five (0.5%) in the noncalcified group (p : 
0.04). Age >65 years (p = 0.04) was the only other univariate 
predictor of death. After controlling for age >65 years, there 
was no further effect of lesion calcification on death (p = 0.10). 
There was no difference in the incidence of Q wave myocardial 
infarction (1.02% vs. 0.46%) or emergency coronary artery 
bypass urgery (1.76% vs. 2.22%) between groups. The non-Q 
wave myocardial infarction rate was 10.0% for calcified and 
7.7% for noncalcified lesions (p = 0.05). 
Discuss ion  
Treatment of calcified lesions. New coronary interven- 
tional devices are unlikely to replace balloon angioplasty as thc 
mainstay of percutaneous treatment of coronary artery disease. 
However, newer devices do provide a different mechanism of 
lumen expansion, and different mechanical approaches may 
improve outcome in specific lesion subsets where balloon 
angioplasty has significant limitations. One of these subsets is 
calcified lesions. The present study indicates that the likelihood 
of procedural success with the Rotablator catheter is not 
reduced by the presence of lesion calcification. The success 
rate of rotational atherectomy was 94.3% in calcified and 
95.2% in noncalcified lesions. A composite nd point of death, 
Q wave myocardial infarction and urgent coronary artery 
bypass urgery was not more frequent in calcified lesions, but 
procedure-related mortality was increased. This increased 
mortality was not significant when corrected for patient age. 
These results are in contradistinction to the reported reduced 
success rate of percutaneous coronary balloon angioplasty 
(1,4,5) and directional atherectomy in calcified lesions (3,11). 
Bredlau et al. (4) reported that major complications occurred 
in 8% of lesions with balloon angioplasty, which was signifi- 
cantly greater than the 3.9% major complication rate seen in 
noncalcified lesions. Myler et al. (1) recently reported success 
and complication rates with balloon angioplasty. Fewer calci- 
fied (91%) than noncalcified lesions (94.8%) were successfully 
treated, and complications were more common in calcified 
than noncalcified lesions (i.e., 3.6% vs. 1.3%, respectively). 
Additionally, 5% of calcified lesions did not respond to balloon 
angioplasty despite high inflation pressures (->16 atm). In one 
report (3) directional coronary atherectomy had only a 70% 
success rate in the presence of calcification. Ellis et al. (11) 
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Figure 2. Calcified lesions (open bars) more frequently 
had multiple other angiographic risk factors than non- 
calcified lesions (solid bars) (p = 0.001). NA - not 
available. 
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Table 4. Success and Complication Rates (hierarchic) 
Calcified Lesions Noncalcified Lesions 
(n = 1,078) (n - 1,083) p Value 
Success 1,016 (94.3%) 1,031 (95.2%) 0.32 
Death 14 (1.3%) 5 (0.5%) 0.04 
Q wave MI 11 (1.0%) 5 (0.5%) 0.13 
CABG 19 (1.7%) 24 (2.2%) 0.45 
Non-Q MI 108 (10.0%) 83 (7.7%) 0.054 
Data presented are number (%) of patients. Success - <50% residual stenosis without death, Q wave myocardial 
infarction (MI) or urgent coronary, artery bypass urgery (CABG). 
reported that the relative risk of atherectomy failure was 
significantly increased (relative risk 1.98) in calcified lesions. 
Mechanism of rotational atherectomy. In contrast, the 
mechanism of plaque removal with the Rotablator catheter is
unique and apparently particularly well suited to calcified 
lesions. Animal (12), cadaver (13) and human in vivo studies 
(14) have shown the Rotablator burr selectively removes rigid 
atherosclerotic lesions, leaving a smooth lumen, especially in 
heavily calcified lesions. Brogan et al. (15) reported a 90% 
procedural success rate with the Rotablator system in 41 
patients in whom balloon angioplasty had previously been 
unsuccessful; 74% of these patients had moderate or heavy 
lesion calcification. However, the approach used with the 
Rotablator was different for calcified and noncalcified vessels 
in the present study. The mean burr/artery ratio was smaller 
for calcified vessels and post-Rotablator balloon angioplasty 
was used more often in this group. The net result was that the 
residual stenoses were similar for the two groups. The smaller 
burr/artery atios used to treat he calcified lesions may reflect 
greater operator caution in treating the calcified lesions. These 
lesions were more frequently complex and >10 mm in length. 
Despite this more cautious approach, non-Q wave myocardial 
infarction was more frequent in the calcified lesion group. This 
finding may reflect the volume of microparticulate d bris 
produced, epicardial or microvascular spasm or other factors 
not addressed in the present study. 
Recent evidence from intravascular ultrasound studies (16) 
indicates that calcification plays an important role in vessel 
dissection caused by balloon angioplasty. Percutaneous trans- 
luminal coronary angioplasty of calcified lesions often requires 
high pressure to "crack" the lesion. This radial pressure 
produces hear forces within the wall that are concentrated at 
the junction of calcified and noncalcified tissues (17), a fre- 
quent site of dissection (16). In the present study, dissection 
was also more frequent after rotational atherectomy of calci- 
fied lesions, although this increased issection rate did not 
result in an increased incidence of abrupt vessel closure, urgent 
coronary artery bypass surgery or Q wave myocardial infarc- 
tion. 
Intracoronary ultrasound may also help identify those pa- 
tients in whom the Rotablator will be most useful. Further 
research may indicate that lesions with extensive superficial 
calcification may be most suitable for treatment with the 
Rotablator, whereas other devices could be used if the calcifi- 
cation is deep to soft or fibrous plaque. The use of intracoro- 
nary ultrasound to guide device selection in individual patients 
requires further investigation. 
Limitations of the study. The present study was not a 
randomized study of the use of the Rotablator catheter in 
calcified lesions but a report from a prospective multicenter 
data base. The degree of calcification was not classified using a 
qualitative scale, and angiographic characteristics were deter- 
mined by individual investigators and not a central angio- 
graphic core laboratory. Similarly, complications were deter- 
Figure 3. Calcification did not reduce the procedural suc- 
cess rate (% Success) when lesions were analyzed by 
number of other angiographic r sk factors (p = NS, calci- 
fied [open bars] vs. noncalcified lesions ]solid bars]). 
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mined by the clinical sites, not by an independent review pancl. 
However, all CK levels were reviewed to determine the 
incidence of non-Q wave myocardial infarction. These data 
represent a broad multicenter clinical experience with the 
Rotablator system in a large number of patients and provide 
the clinician with preliminary information to guide patient 
selection for use of this recently approved technique. 
Summary. The success rate of rotational atherectomy was 
not reduced by calcification despite the more frequent complex 
nature of the calcified lesions. Procedural success rates were 
high and compare favorably with historical control data for 
other devices. Major procedural complications were not signif- 
icantly more frequent in calcified lesions. The nonrandomized 
data in the present study need to be confirmed by a prospective 
randomized trial. However, the present study indicates that 
calcified coronary artery lesions can be successfully treated by 
high speed rotational atherectomy. 
We thank Dawn Tavis, Lori Bodeau, BS and Dan Yamasaki, MS of Heart 
Technology, Inc. 
Appendix 
Participating Institutions and Co-Investigators for 
the Multicenter Rotablator Registry 
Theodore Bass, Univemty of Florida tteahh Sciences Center. Jacksonville. 
Florida; Michel Bertrand, Hopital Cardiologique, Lille. France; Maurice Buch- 
binder, University of Cali~bmia San Diego Medical Center, San Diego, California: 
Michael Cleman, Yale School of Medieine. New Haven, Connecticut; Barry Cohen, 
Newark Beth Israel Medical Center, Newark, New Jersey; Michael Cowley. Medical 
College of Virginia, Richmond, lfirginia; Gerald Dorros, St. Luke's Medical Center. 
Milwaukee, Wisconsin; Raimund Erbel, Johannes Gutenberg Univarsitat. Mainz, 
Germany: Jean Louis Fourrier, Clinique de la Louview, Lille, France: Robert 
Ginsburg, Stanford Universi6, Pulp Aho, California; Robert Kipperman and 
Jospeh Galichia, Wichita Institute.]'or Medical Research, Wichita, Kansas: Martin 
Leon, Washington Heart Center, Washington, D.C.: Jean Marco, Clinique Pasteur; 
Toulouse, France; Todd Sherman, UCLA Medical Center, Los Angeles, California: 
Richard Spring, Washoe Medical Center, Reap, Nevada: Simon Stertzer, San 
Franciseo Heart Institute, Duly City, CaliJornia; David Warth, Providence Medical 
Center, Seattle, Washington; Patrick Whitlow, Cleveland Clinic, Clevehmd, Ohio; 
William O'Neill, William Beaumont Hospital. R(~val Oak. Mieh~ean; Nadim Zacca. 
Methodist Hospital, Houston, Texas. 
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